Integrated Genomic and Proteomic Analyses Reveal Novel Mechanisms of the Methyltransferase SETD2 in Renal Cell Carcinoma Development - ScienceDirect
Simple and sensitive GC/MS-method for the quantification of urinary phenol, o- and m-cresol and ethylphenols as biomarkers of exposure to industrial solvents - ScienceDirect
PDF) Loss of SETD2 Induces a Metabolic Switch in Renal Cell Carcinoma Cell Lines toward Enhanced Oxidative Phosphorylation
EU Regulation Compliant GC-MS/MS Method Package for Dioxins in Foods - Features : Shimadzu Scientific Instruments
Hepatic lipid profile in the LDLR knockout rats. Lipids were extracted
Prkdc gene editing strategy and outcomes, ZFN design and gene
RNA-seq analysis of 786-O and isogenic SETD2-deficient 38E and 38F
SETD2 deficiency accelerates sphingomyelin accumulation and promotes the development of renal cancer
177 Lu-DOTATATE selectively killed hSSTr2 + ESCs in vitro. (A) hSSTr2 +
summarises engraftment, vector copy number (VCN), phenotypical analyses
